Open AccessReducing global risk for cardiovascular disease: Using lifestyle changes and pharmacotherapy
Author(s) -
Cheng Alan,
Braunstein Joel B.,
Dennison Cheryl,
Nass Caitlin,
Blumenthal Roger S.
Publication year - 2002
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.4950250503
Subject(s) - medicine , disease , glycemic , intensive care medicine , primary prevention , smoking cessation , pharmacotherapy , blood pressure , diabetes mellitus , cause of death , risk factor , psychological intervention , polypill , environmental health , physical therapy , pathology , endocrinology , psychiatry
Cardiovascular disease (CVD) is the leading cause of death and disability in industrialized societies, due in large part to the lack of a comprehensive approach to control the risk factors for atherosclerosis. One strategy for reducing an individual's global CVD risk relies on a targeted approach that modifies each of the major independent risk factors prevalent in both symptomatic (secondary prevention) and asymptomatic (primary prevention) patients. These interventions include lipid lowering, smoking cessation, blood pressure control, glycemic control, regular exercise, and the use of various medications. This review offers an evidence‐based strategy toward reducing an individual's global risk for CVD by addressing the modifiable, major independent risk factors.